These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15975041)

  • 1. Trimethylamine: metabolic, pharmacokinetic and safety aspects.
    Bain MA; Fornasini G; Evans AM
    Curr Drug Metab; 2005 Jun; 6(3):227-40. PubMed ID: 15975041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis.
    Bain MA; Faull R; Fornasini G; Milne RW; Evans AM
    Nephrol Dial Transplant; 2006 May; 21(5):1300-4. PubMed ID: 16401621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimethylaminuria and a human FMO3 mutation database.
    Hernandez D; Addou S; Lee D; Orengo C; Shephard EA; Phillips IR
    Hum Mutat; 2003 Sep; 22(3):209-13. PubMed ID: 12938085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trimethylamine and Trimethylamine N-Oxide, a Flavin-Containing Monooxygenase 3 (FMO3)-Mediated Host-Microbiome Metabolic Axis Implicated in Health and Disease.
    Fennema D; Phillips IR; Shephard EA
    Drug Metab Dispos; 2016 Nov; 44(11):1839-1850. PubMed ID: 27190056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoform specificity of trimethylamine N-oxygenation by human flavin-containing monooxygenase (FMO) and P450 enzymes: selective catalysis by FMO3.
    Lang DH; Yeung CK; Peter RM; Ibarra C; Gasser R; Itagaki K; Philpot RM; Rettie AE
    Biochem Pharmacol; 1998 Oct; 56(8):1005-12. PubMed ID: 9776311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of trimethylaminuria (FMO3 deficiency) in children.
    Chalmers RA; Bain MD; Michelakakis H; Zschocke J; Iles RA
    J Inherit Metab Dis; 2006 Feb; 29(1):162-72. PubMed ID: 16601883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dioxin-like pollutants increase hepatic flavin containing monooxygenase (FMO3) expression to promote synthesis of the pro-atherogenic nutrient biomarker trimethylamine N-oxide from dietary precursors.
    Petriello MC; Hoffman JB; Sunkara M; Wahlang B; Perkins JT; Morris AJ; Hennig B
    J Nutr Biochem; 2016 Jul; 33():145-53. PubMed ID: 27155921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human flavin-containing monooxygenase form 3: cDNA expression of the enzymes containing amino acid substitutions observed in individuals with trimethylaminuria.
    Cashman JR; Bi YA; Lin J; Youil R; Knight M; Forrest S; Treacy E
    Chem Res Toxicol; 1997 Aug; 10(8):837-41. PubMed ID: 9282831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphism of the flavin-containing monooxygenase 3 (FMO3) associated with trimethylaminuria (fish odor syndrome): observations from Japanese patients.
    Yamazaki H; Shimizu M
    Curr Drug Metab; 2007 Jun; 8(5):487-91. PubMed ID: 17584019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and clinical aspects of the human flavin-containing monooxygenase form 3 (FMO3) related to trimethylaminuria.
    Cashman JR; Camp K; Fakharzadeh SS; Fennessey PV; Hines RN; Mamer OA; Mitchell SC; Nguyen GP; Schlenk D; Smith RL; Tjoa SS; Williams DE; Yannicelli S
    Curr Drug Metab; 2003 Apr; 4(2):151-70. PubMed ID: 12678693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimethylaminuria (fish odor syndrome): genotype characterization among Portuguese patients.
    Ferreira F; Esteves S; Almeida LS; Gaspar A; da Costa CD; Janeiro P; Bandeira A; Martins E; Teles EL; Garcia P; Azevedo L; Vilarinho L
    Gene; 2013 Sep; 527(1):366-70. PubMed ID: 23791655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism and excretion of methylamines in rats.
    Smith JL; Wishnok JS; Deen WM
    Toxicol Appl Pharmacol; 1994 Apr; 125(2):296-308. PubMed ID: 8171437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimethylaminuria.
    Kloster I; Erichsen MM
    Tidsskr Nor Laegeforen; 2021 Sep; 141():. PubMed ID: 34597008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human plasma and urinary metabolic profiles of trimethylamine and trimethylamine N-oxide extrapolated using a simple physiologically based pharmacokinetic model.
    Shimizu M; Yamazaki H
    J Toxicol Sci; 2017; 42(4):485-490. PubMed ID: 28717107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Individual differences of drug-metabolizing enzymes as determinants for the metabolic fate of chemicals--a study of trimethylamine and flavin-containing monooxygenase 3-].
    Shimizu M
    Yakugaku Zasshi; 2009 Nov; 129(11):1351-6. PubMed ID: 19881207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between flavin-containing mono-oxygenase 3 (FMO3) genotype and trimethylaminuria phenotype in a Japanese population.
    Shimizu M; Allerston CK; Shephard EA; Yamazaki H; Phillips IR
    Br J Clin Pharmacol; 2014 May; 77(5):839-51. PubMed ID: 24028545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stop codon mutations in the flavin-containing monooxygenase 3 (FMO3) gene responsible for trimethylaminuria in a Japanese population.
    Yamazaki H; Fujita H; Gunji T; Zhang J; Kamataki T; Cashman JR; Shimizu M
    Mol Genet Metab; 2007 Jan; 90(1):58-63. PubMed ID: 16996766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel variants of the human flavin-containing monooxygenase 3 (FMO3) gene associated with trimethylaminuria.
    Motika MS; Zhang J; Zheng X; Riedler K; Cashman JR
    Mol Genet Metab; 2009 Jun; 97(2):128-35. PubMed ID: 19321370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of trimethylamine in rats, including the effects of a synthetic diet.
    Nnane IP; Damani LA
    Xenobiotica; 2001 Oct; 31(10):749-55. PubMed ID: 11695853
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.